[Studies on the changes of the daily amount of tubercle bacilli present in sputum and their resistance against drugs, when patients have been treated with antituberculous agents. II. Combined therapy with SM-PAS: PAS-INH: SM-INH: or sulfisoxazol-INH].
D001407:Bacillus; D006801:Humans; D013183:Sputum; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
SULFONAMIDES/therapeutic use; TUBERCULOSIS, PULMONARY/therapy